Due to COVID-19 we are now offering TeleHealth Office Visits via video or phone call. Learn More >
We have prepared for the Coronavirus (COVID-19). We have updated policies to protect our patients and staff. Learn more.

How Advanced Immunotherapy is Transforming the Lives of Cancer Patients in Texas

The future of cancer treatment lies in advanced immunotherapy options. Immunotherapy is the treatment of cancer that is designed to boost the natural ability of the body to fight cancer by restoring the function of the immune system. A compromised immune system fails to destroy dangerous cells, allowing cancer to develop. More often cancer cells find ways of blocking the immune system from working.

Proper immunotherapy treatment can help overcome many cancer survival mechanisms because it operates independently. Not all immunotherapy treatments are the same though; it has to be tailored to the needs of the patient – the compromised parts of the immune system are the ones to be activated. The results of immunotherapy treatment vary from person to person.

Advanced immunotherapy is gaining popularity in the treatment of cancer:

  • Immune Modulation Therapy (IMX) is an advanced form of immunotherapy that trains the body to identify and kill the cancer cells in a patient. IMX uses a multi-step approach which utilizes genetic dendritic peptides, oncolytic viruses, checkpoint inhibitors and expanded natural killer cells.
  • Immunotherapy does not weaken the immune system, but treatments like radiation and chemotherapy do.
  • Specialized immunotherapy methods can be utilized as adjunctive or integrative treatments to other standard treatments like chemotherapy and radiation. Immunotherapy has been clinically proven to be of help in improving the quality of life and even cancer remission.

Immunotherapy is being incorporated into more treatments, thanks to the advent of smart drugs in the form of checkpoint inhibitors. It is not enough though, because many of the immunotherapy treatments do not have the multi-step approach that IMX utilizes. If they had, there would be a huge positive difference for difficult to treat and late-stage cancers. Immunotherapies are still not a one-size-fits-all approach to cancer treatment because potentially, each patient needs a combination of different therapies (medical genetic blueprint) that works best for their unique cancer type.

More Choice Cancer Care Centers